Jennison Associates
AVNR

Jennison Associates’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Jennison Associates’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,200,000
Closed -$14.3M – 795
2014
Q3 		$14.3M Buy
+1,200,000
New +$8.19M 0.01% 463

Other funds holding AVNR

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jennison Associates's AVNR Position: Q4 2014 in Review

Jennison Associates sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q4 2014, closing a stake of 1,200,000 shares — an estimated $14.3M sold.

Jennison Associates first reported a position in AVNR in Q3 2014 and held it in 1 quarter. The position peaked at $14.3M in Q3 2014. 166 funds tracked by Wall St. Rank hold AVNR as of Q4 2014.

  • Jennison Associates reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q4 2014 after selling out during the quarter.
  • Jennison Associates sold 1,200,000 AVANIR PHARMACEUTICALS, INC CL A shares in Q4 2014, an estimated $14.3M.
  • Jennison Associates first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2014 and held it in 1 quarter.
  • Jennison Associates's AVANIR PHARMACEUTICALS, INC CL A position peaked at $14.3M in Q3 2014.
  • 166 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q4 2014.

Based on Jennison Associates's 13F filing for Q4 2014, filed 6 Feb 2015.